Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Aarti Drugs Targets 15-16% EBITDA Margin On Higher Sayakha Utilisation, Metformin Volumes: CFO

    9 hours ago

    Adhish P. Patil, Chief Financial Officer of Aarti Drugs, said the company expects utilisation at the facility to rise to 80-85% within the next two quarters, which should significantly improve gross contribution.
    Click here to Read More
    Previous Article
    When NextGen Doesn't Need To Work, Then What?
    Next Article
    H1N1 Cases Surge: Should You Get Influenza Vaccine? Check Symptoms And Treatment

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment